Search

everythinglearnresearchcommunity

for

Search:↓

New dissolving and implantable microneedle patches have been created for a long-lasting, non-invasive delivery of the drug finasteride.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

The patch effectively promotes hair growth for alopecia areata without pain.

The method improves acne treatment by enhancing drug delivery and reducing skin irritation.

The Unani Pharmacopoeia-Based Formulation significantly improved symptoms of enlarged prostate in rats.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Azelaic acid in a special gel is more effective against skin fungi than regular azelaic acid.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Different medications can cause serious side effects in some people.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

AFL is safe and effective for topical drug delivery but needs larger studies and cheaper devices for wider use.

Ritlecitinib can help about 14,000 people with severe hair loss.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

A new treatment using unactivated platelet leukocyte autoplasma cured 80% of non-scarring alopecia patients.

Croton membranaceus root extract can change how drugs are processed in the body.

Agaricus bisporus β-Glucan particles could effectively treat cervical cancer and offer antimicrobial and antioxidant benefits.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.